News-Papers
Testimonial
Video Gallery
Combination of isotretinoin and calcitriol for precancerous and cancerous skin lesions
Published on Friday, 21 July 2017
Combination of isotretinoin and calcitriol for precancerous and cancerous skin lesions
See also:
- All-Trans-Retinoic Acid (ATRA - analogues and/or derivatives);
- Solution of retinoids in vitamin E in the Di Bella Method biological multitherapy;
- Vitamin D (analogues and/or derivatives) and cancer;
- Large B-cells Non-Hodgkin's Lymphoma, Stage IV-AE: a Case Report;
Search
Follow us...
Latest
- Melatonin, an inhibitory agent in breast cancer
- Melatonin: an inhibitor of breast cancer
- Therapeutic treatments potentially mediated by melatonin receptors: potential clinical uses in the prevention of osteoporosis, cancer and as an adjuvant therapy
- Differential expression of high-affinity melatonin receptors (MT1) in normal and malignant human breast tissue
- In Vitro Investigations on the Antioxidant Effects of Vitamin D in a Panel of Cancer Cell Lines
- Melatonin Inhibits Gastric Cancer Cell Proliferation by Suppressing Exosome miR-27b-3p Expression
- Vitamin D deficiency as a risk factor for thyroid cancer: A meta-analysis of case-control studies
- Melatonin and its therapeutic prospects in gastroenterology
- Catecholamines Mediate Psychologic Stress-Induced Cancer Progression
- Psychologic Stress Drives Progression of Malignant Tumors via DRD2/HIF1α Signaling
- Melatonin Alleviates Acute Respiratory Distress Syndrome by Inhibiting Alveolar Macrophage NLRP3 Inflammasomes Through the ROS/HIF-1α/GLUT1 Pathway
- The potential therapeutic effect of melatonin on human ovarian cancer by inhibition of invasion and migration of cancer stem cells
- Melatonin Supplementation Improves Pain, Sleep Quality, and Total Plasma Antioxidant Capacity in Women with Fibrocystic Breast Disease: A Randomized, Double-blind, Placebo-controlled Trial
- Melatonin as antioxidant, geroprotector and anticarcinogen
- Pretreatment with melatonin protects against cyclophosphamide-induced oxidative stress and renal damage in mice
- The role of calcium and vitamin D dietary intake on risk of colorectal cancer: systematic review and meta-analysis of case-control studies
- SSTR2-targeting therapy in EBV-positive and EBV-negative metastatic nasopharyngeal carcinoma
- Melatonin Represses Metastasis in Her2-Postive Human Breast Cancer Cells by Suppressing RSK2 Expression
Most Read
- The Di Bella Method (DBM)
- About melatonin - 1996
- All-trans-retinoic acid and cancer
- Biography
- The Di Bella Method Increases by the 30% the survival rate for Pancreas tumors and for this reason should be proposed as first line therapy for this type of cancer
- Chronic Lymphocytic Leukemia: 4 patients, long-lasting remission
- Somatostatin in oncology, the overlooked evidences
- Treatment of Low-grade Non-Hodgkin’s Lymphomas at Advanced Stage
- How effective is chemo therapy?
- Bibliography
- Complete objective response to biological therapy of plurifocal breast carcinoma
- Large B-cells Non-Hodgkin's Lymphoma, Stage IV-AE: a Case Report
- Non-Hodgkin's Lymphoma, Stage III-B-E: a Case Report
- Vademecum
- Frequently Asked Questions
- Declaration recommends eliminate the use of Impact factor for research evaluation
- Non–Small-Cell Lung Cancer Patients with Low Performance Status: study on 28 patients
- Breast cancer: study on 122 cases. The Di Bella Method (DBM) improved survival, objective response and performance status in a retrospective observational clinical study on 122 cases of breast cancer